Annovis Bio, Inc.
ANVS
$1.57
-$0.07-4.27%
NYSE
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 83.36% | 98.85% | -74.58% | -81.28% | -79.72% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 785.30% | 98.75% | 84.23% | 2,317.14% | -60.44% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -31.86% | -60.69% | -89.37% | -49.18% | -41.48% |
Total Current Assets | 36.41% | 40.48% | -77.88% | -69.42% | -71.66% |
|
|||||
Total Current Assets | 36.41% | 40.48% | -77.88% | -69.42% | -71.66% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 36.41% | 40.48% | -77.88% | -69.42% | -71.66% |
|
|||||
Total Accounts Payable | 78.37% | 112.80% | 189.43% | -1.11% | -67.36% |
Total Accrued Expenses | -47.26% | -21.15% | -26.45% | -39.35% | -20.09% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -9.30% | 51.24% | 95.65% | -10.00% | -44.42% |
|
|||||
Total Current Liabilities | -9.30% | 51.24% | 95.65% | -10.00% | -44.42% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -94.61% | -- | -- | -- | -- |
Total Liabilities | -74.29% | 104.72% | 227.77% | 106.37% | 133.28% |
|
|||||
Common Stock & APIC | 40.63% | 43.66% | 21.82% | 28.65% | 24.44% |
Retained Earnings | -22.30% | -46.50% | -58.66% | -74.51% | -103.98% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 220.09% | 6.09% | -108.44% | -116.66% | -127.37% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 220.09% | 6.09% | -108.44% | -116.66% | -127.37% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 220.09% | 6.09% | -108.44% | -116.66% | -127.37% |
|